XM tidak memberikan layanan kepada penduduk Amerika Serikat.

STOXX 600 recovers early losses on US jobs data relief



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-STOXX 600 recovers early losses on US jobs data relief</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window

Novo rebounds on positive read-across from Lilly

Siemens jumps after profit beat

Allianz rises on Q2 beat

Deutsche Telekom up after increase in Q2 core earnings

STOXX 600 up 0.1%

Updates at 1600 GMT

By Ankika Biswas and Pranav Kashyap

Aug 8 (Reuters) -Europe's benchmark stock index recouped early losses to close slightly higher on Thursday, helped by encouraging U.S. jobs market data and as the heavy-weight healthcare sector got a boost from Novo Nordisk's recovery.

The STOXX 600 .STOXX closed 0.1% higher, after a sharp early decline in technology stocks knocked the pan-European index down over 1% intraday.

Data showed weekly U.S. jobless claims fell more than expected, suggesting fears of a sharp weakening in the labour market, which in part had fuelled U.S. recession fears, were overblown.

"Just because the labour market is cooling off doesn't mean we're (U.S.) entering into a recession. While there has been renewed worry about the labour market, we believe it's overblown," said from Skyler Weinand, chief investment officer, Regan Capital.

As European stocks recovered after the data, Wall Street also enjoyed strong gains for the day.

The STOXX 600 has been volatile this week as investors evaluated fears of a potential U.S. recession and looked for clear macroeconomic signals, both at home and globally.

German inflation data, due on Friday, will give investors a clearer picture on Europe's largest economy as it teeters on the verge of a recession.

Europe's largest company by market value, Novo Nordisk NOVOb.CO, rose 4.3%, recovering more than half of Wednesday's near 7% slide, as rival Eli Lilly's LLY.N raised its annual sales forecast, boding well for the Danish drug maker.

Healthcare .SXDP was among the top sectoral gainers, also boosted by a 8.3% jump in British drugmaker Hikma Pharmaceuticals HIK.L on an upbeat annual outlook, while media .SXMP was the worst hit sector.

Allianz ALVG.DE gained 2% after the German insurer posted a better-than-expected rise in second-quarter net profit and said it was on track to meet its full-year target.

Several other European insurers recorded bumper first-half profits on Thursday, such as Zurich Insurance ZURN.S, Munich Re MUVGn.DE and London's Beazley BEZG.L.

Siemens SIEGn.DE rose 2.1% after beating quarterly earnings forecasts.

Deutsche Telekom DTEGn.DE was up 1.9% after the telecom firm reported a 7.8% increase in its second-quarter core earnings, while Entain ENT.L climbed 5% as the British gambling group raised its annual revenue forecast.

Meanwhile, valve maker Spirax-Sarco Engineering SPX.L dropped 7.4% after results, while German sportswear maker Puma PUMG.DE fell 4% as a raft of brokerage price-target cuts followed Wednesday's dismal earnings.



Reporting by Pranav Kashyap and Ankika Biswas in Bengaluru; Editing by Sonia Cheema, Varun H K and Christina Fincher

</body></html>

Pengungkapan: Entitas XM Group menyediakan layanan khusus eksekusi dan akses ke Fasilitas Trading Online kami, yang memungkinkan Anda untuk melihat dan/atau menggunakan konten yang tersedia pada atau melalui situs, yang tidak untuk mengubah atau memperluas, serta tidak mengubah atau memperluas hal tersebut. Akses dan penggunaan ini selalu sesuai dengan: (i) Syarat dan Ketentuan; (ii) Peringatan Risiko; dan (iii) Pengungkapan Penuh. Oleh karena itu, konten disediakan hanya sebagai informasi umum. Anda juga harus ketahui bahwa konten Fasilitas Trading Online kami bukan sebagai ajakan atau tawaran untuk untuk melakukan transaksi apa pun di pasar finansial. Trading di pasar finansial mana pun melibatkan tingkat risiko yang signifikan pada modal Anda.

Semua materi yang diterbitkan di Fasilitas Trading Online kami hanya untuk tujuan edukasi/informasi dan tidak boleh mengandung nasihat dan rekomendasi finansial, pajak investasi atau trading, catatan harga trading kami, penawaran, permintaan, transaksi dalam instrumen finansial apa pun atau promo finansial untuk Anda yang tidak diminta.

Konten pihak ketiga apa pun, serta konten yang disiapkan oleh XM, seperti opini, berita, riset, analisis, harga, informasi lain atau link ke situs pihak ketiga yang tersedia "sebagaimana adanya", sebagai komentar pasar umum dan bukan menjadi nasihat investasi. Sejauh konten apa pun ditafsirkan sebagai penelitian investasi, Anda harus memperhatikan dan menerima bahwa konten tersebut tidak dimaksudkan dan belum disiapkan sesuai dengan persyaratan hukum yang dirancang untuk mempromosikan kemandirian riset investasi dan dengan demikian akan dianggap sebagai komunikasi pemasaran di bawah hukum dan peraturan yang relevan. Mohon dipastikan bahwa Anda telah membaca dan memahami Notifikasi pada Riset Investasi Non-Independen dan Peringatan Risiko kami mengenai informasi di atas, yang dapat diakses disini.

Peringatan Resiko: Modal Anda beresiko. Produk dengan leverage mungkin tidak cocok bagi semua orang. Silahkan pertimbangkan Pengungkapan Resiko kami.